We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Diagnostic Validity of Citric Acid-Free, High Dose <sup>13</sup> C-Urea Breath Test After Helicobacter pylori Eradication in Korea.
- Authors
Kwon, Yong Hwan; Kim, Nayoung; Lee, Ju Yup; Choi, Yoon Jin; Yoon, Kichul; Hwang, Jae Jin; Lee, Hyun Joo; Lee, AeRa; Jeong, Yeon Sang; Oh, Sooyeon; Yoon, Hyuk; Shin, Cheol Min; Park, Young Soo; Lee, Dong Ho
- Abstract
Background The 13C-urea breath test (13C- UBT) is a noninvasive method for diagnosing Helicobacter pylori ( H. pylori) infection. The aims of this study were to evaluate the diagnostic validity of the 13C- UBT cutoff value and to identify influencing clinical factors responsible for aberrant results. Methods 13C- UBT ( UBiTkit; Otsuka Pharmaceutical, cutoff value: 2.5‰) results in the range 2.0‰ to 10.0‰ after H. pylori eradication therapy were compared with the results of endoscopic biopsy results of the antrum and body. Factors considered to affect test results adversely were analyzed. Results Among patients with a positive 13C- UBT result (2.5‰ to 10.0‰, n = 223) or a negative 13C- UBT result (2.0‰ to < 2.5‰, n = 66) after H. pylori eradication, 73 patients (34.0%) were false positive, and one (1.5%) was false negative as determined by endoscopic biopsy. The sensitivity, specificity, false-positive rate, and false-negative rate for a cutoff value of 2.5‰ were 99.3%, 47.1%, 52.9%, and 0.7%, respectively, and positive and negative predictive values of the 13C- UBT were 67.3% and 98.5%, respectively. Multivariate analysis showed that a history of two or more previous H. pylori eradication therapies ( OR = 2.455, 95% CI = 1.299-4.641) and moderate to severe gastric intestinal metaplasia ( OR = 3.359, 95% CI = 1.572-7.178) were associated with a false-positive 13C- UBT result. Conclusion The 13C- UBT cutoff value currently used has poor specificity for confirming H. pylori status after eradication, and this lack of specificity is exacerbated in patients that have undergone multiple prior eradication therapies and in patients with moderate to severe gastric intestinal metaplasia. In addition, the citric-free 13C- UBT would increase a false-positive 13C- UBT result.
- Subjects
HELICOBACTER pylori infections; TREATMENT of helicobacter pylori infections; CITRIC acid; MULTIVARIATE analysis; MEDICAL microbiology; GASTROENTEROLOGY; DIAGNOSIS
- Publication
Helicobacter, 2015, Vol 20, Issue 3, p159
- ISSN
1083-4389
- Publication type
Article
- DOI
10.1111/hel.12189